Maria Betty Grace Bontigao-Emocling: 7 Years of Purpose-Driven Leadership at Boehringer Ingelheim
Maria Betty Grace Bontigao-Emocling, Therapeutic Area Lead – Cardiovascular and Lytics Business at Boehringer Ingelheim, shared a post on LinkedIn:
”Celebrating 7 years at Boehringer Ingelheim today-and feeling incredibly proud of the journey.
Over the years, I’ve been entrusted to lead and contribute across cardiovascular, respiratory, specialty care, rare disease, and now thrombosis care.
Each therapeutic area brought new challenges, deeper responsibility, and the opportunity to grow as a leader.
I’m grateful for leaders who believed in me, mentors who challenged me, and teammates who consistently show what excellence and collaboration look like. It’s an honor to help shape patient journeys and work alongside passionate key opinion leaders who share the same purpose.
Most proud to be leading a dynamic, resilient, and high‑performing One Stroke Care Team-a group driven by impact, teamwork, and commitment to patients.
Looking forward to more milestones, growth, and meaningful impact in the years ahead.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers